Global Biosimilars Market
Report Highlights
The global Biosimilars Market was valued at USD 3.23 billion in 2016 and is projected to reach USD 26.40 billion by 2025, growing at a CAGR of 26.29% from 2017 to 2025.
A biosimilar (also known as follow-on biologic or subsequent entry biologic) is a biologic medical product which is almost an identical copy of an original product.
Market Dynamics:
1. Market Drivers
1.1 Rising Incidences of Diseases
1.2 Increasing Demand for Biosimilar Drugs Due to Their Cost-Effectiveness
1.3 Growing Pressure to Curtail Healthcare Expenditure
1.4 Growing Geriatric Population
1.5 Strategic Collaborations Resulting in Enhanced Productivity and Clinical Trial Activities for Biosimilars
1.6 Increasing Government Support
2. Market Restraints
2.1 Complexities in Manufacturing and High Costs
2.2 Innovative Strategies By Biologic Drug Manufacturers
Market Segmentation:
1. Global Biosimilars Market, by Application:
1.1 Oncology
1.2 Chronic and Autoimmune Diseases
1.3 Blood Disorders
1.4 Growth Hormone Deficiency
1.5 Infectious Diseases
1.6 Other Applications
2. Global Biosimilars Market, by Manufacturing:
2.1 In-House Manufacturing
2.2 Contract Manufacturing Organizations
3. Global Biosimilars Market, by Type Of Product:
3.1 Recombinant Non-Glycosylated Proteins
3.1.1 Insulin
3.1.2 Recombinant Human Growth Hormone (RHGH)
3.1.3 Granulocyte Colony-Stimulating Factor (Filgrastim)
3.1.4 Interferons
3.2 Recombinant Glycosylated Proteins
3.2.1 Erythropoietin (EPO)
3.2.2 Monoclonal Antibodies (MABS)
3.2.3 Follitropin
3.3 Recombinant Peptides
3.3.1 Glucagon
3.3.2 Calcitonin
4. Global Biosimilars Market, by Region:
4.1 North America (U.S., Canada, Mexico)
4.2 Europe (Germany, UK, France, Rest of Europe)
4.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
4.4 Latin America (Brazil, Argentina, Rest of Latin America)
4.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Pfizer Inc.
2. Sandoz International GmbH (A Division of Novartis International AG)
3. Teva Pharmaceutical Industries Ltd.
4. F. Hoffmann-La Roche Ltd.
5. Amgen Inc.
6. Biocon Ltd.
7. Dr. Reddy's Laboratories
8. Celltrion Inc.
9. Mylan Inc.
10. Samsung Bioepis
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the BiosimilarsMarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.